Skip to main content
CAPR
NASDAQ Life Sciences

Deramiocel Meets Phase 3 HOPE-3 Primary Endpoint, But Cardiac Data Miss

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$8.77
Mkt Cap
$488.975M
52W Low
$2.96
52W High
$40.37
52W Position info
196% above low
Off High info
78% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CAPR has more than doubled off its 52-week low of $2.96.

Summary

Capricor's deramiocel hit the primary endpoint in the Phase 3 HOPE-3 trial, improving upper-limb function in Duchenne muscular dystrophy patients. The cardiac side was weaker: overall heart function results were not statistically significant, extending the LVEF disappointment already flagged when the key secondary endpoint came in at p=0.09. That split matters because the FDA is weighing the BLA right now, with the PDUFA action date pushed to November 22, 2026 — four days from now. A third-party estimate puts approval odds at 62%, which is a coin-flip with a positive tilt, not a lock. The company has roughly $198.5 million in cash after a $42.7 million Q3 loss and a 10% workforce cut in September, so a complete response letter would leave it burning cash while it regroups. Watch November 22 for the FDA decision.

At the time of this announcement, CAPR was trading at $8.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $489M. The 52-week trading range was $2.96 to $40.37. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CAPR - Latest Insights

CAPR
Nov 10, 2026, 5:25 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.35
Real-time Price: $8.77 info
Change: -$0.580 (-6%) info
Market Cap: $488.975M info
CAPR
Nov 10, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $9.10
Real-time Price: $8.77 info
Change: -$0.330 (-4%) info
Market Cap: $488.975M info
CAPR
Nov 10, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.91
Real-time Price: $8.77 info
Change: -$0.135 (-2%) info
Market Cap: $488.975M info
CAPR
Nov 09, 2026, 9:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $9.08
Real-time Price: $8.77 info
Change: -$0.313 (-3%) info
Market Cap: $488.975M info
CAPR
Oct 05, 2026, 12:12 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $8.22
Real-time Price: $8.77 info
Change: +$0.550 (+7%) info
Market Cap: $488.975M info